Recursion Pharmaceuticals
clinical target us patients diagnosed with cancer in in response tumor clearance alpha series achieves while minimizing peripheral inflammation | Recursion Pharmaceuticals
Deck Type
Deck date
January 2023
Slide
59 of 143
Similar slides by Recursion Pharmaceuticals
Investor Day
January 2023
Investor Day
January 2023
Investor Day
January 2023
Investor Day
January 2023
Related slides by other companies
Investor Day
December 2023
Investor Day
February 2024
Results
May 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io